Overview
Mirian Brink practices practicing medicine in Utrecht, Netherlands.
Ms. Brink is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and B-Cell Lymphoma.
She is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mirian Brink
Is Mirian Brink a top-rated expert for Peripheral T-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Mirian Brink is classified as an Advanced expert for Peripheral T-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mirian Brink participate in research or clinical trials?
Yes. Mirian Brink has published 26 articles and abstracts on conditions like Peripheral T-Cell Lymphoma. You can view a list of Mirian Brink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMs. Brink isAdvanced. Learn about B-Cell Lymphoma.
- Large-Cell Immunoblastic Lymphoma
- Non-Hodgkin LymphomaMs. Brink isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaMs. Brink isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- T-Cell LymphomaMs. Brink isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Adult T-Cell LeukemiaMs. Brink isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaMs. Brink isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaMs. Brink isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Chronic T-Cell Leukemia (CTCL)Ms. Brink isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Brink isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hereditary PancreatitisMs. Brink isExperienced. Learn about Hereditary Pancreatitis.
- LeukemiaMs. Brink isExperienced. Learn about Leukemia.
- Lymphofollicular HyperplasiaMs. Brink isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mantle Cell Lymphoma (MCL)Ms. Brink isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Ms. Brink isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Multiple MyelomaMs. Brink isExperienced. Learn about Multiple Myeloma.
- Prolymphocytic LeukemiaMs. Brink isExperienced. Learn about Prolymphocytic Leukemia.
- Testicular CancerMs. Brink isExperienced. Learn about Testicular Cancer.